Business Standard

Glenmark Life Sciences Share Price

Know More
BSENSE

1,027.15-11.60 (-1.12%)

09:43 AM, 13-Dec-2024

1,027.90-8.45 (-0.82%)

09:29 AM, 13-Dec-2024

BSE : 543322

NSE : GLS

Sector : Health care

ISIN Code : INE03Q201024

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 13-Dec-2024 | 09:43 AM IST

Market Cap (₹ Cr)

12,588

Traded Value (₹ Cr)

0.11

Volume (Shares)

1,102

Face Value (₹)

2

52-Week High (₹)

1,335.00

52-Week High Date

16-Sep-2024

52-Week Low (₹)

627.25

52-Week Low Date

21-Dec-2023

All Time High (₹)

1,335.00

All Time High Date

16-Sep-2024

All Time Low (₹)

369.00

All Time Low Date

22-Feb-2023

Glenmark Life Sciences Ltd

Glenmark Life Sciences Limited was incorporated as `Zorg Laboratories Private Limited' on June 23 2011 at Pune and was granted the Certificate of Incorporation by the Registrar of Companies Maharashtra at Pune. Subsequently the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to `Glenmark Life Sciences Private Limited' dated 10 August 2018. A shareholders' resolution was passed on 13 August 2018 to convert the Company from a Private Limited Company to a Public Limited Company and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The Company is a wholly owned Su...
Read More

Glenmark Life News

Pharma shares shine; Dr Reddy's, FDC, Glenmark, Suven trade at record highs

4 min read

IGI IPO subscription opens today: GMP up 18%; Should you bid or avoid?

3 min read

Defence Ministry's Sukhoi deal boosts Hindustan Aeronautics shares by 2%

4 min read

Stock Market LIVE Updates: Sensex drops 500 pts to 80,750; Nifty below 24,400; All sectors in red

6 min read

Jungle Camps India IPO allotment today: Check status, GMP, and more

2 min read
More

Glenmark Life Sciences Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

12,597

EPS - TTM (₹) [C]

28.69

P/E Ratio (X) [C]

35.83

Face Value (₹) 2
Latest Dividend (%)1,125.00
Latest Dividend Date 17-Oct-2023
Dividend Yield (%) 4.82
Book Value Share (₹) [C]147.95
P/B Ratio (₹) [C]6.95

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Quant Flexi Cap Fund - Direct (IDCW) 117.98 10,88,244 1.61
Quant Flexi Cap Fund - Direct (G) 117.98 10,88,244 1.61
Quant Flexi Cap Fund (G) 117.98 10,88,244 1.61
Quant Flexi Cap Fund (IDCW) 117.98 10,88,244 1.61
Quant Business Cycle Fund - Direct (IDCW) 53.93 4,97,480 3.51
Quant Business Cycle Fund - Direct (G) 53.93 4,97,480 3.51
Quant Business Cycle Fund - Regular (G) 53.93 4,97,480 3.51
Quant Business Cycle Fund - Regular (IDCW) 53.93 4,97,480 3.51
ICICI Pru P.H.D Fund - Direct (G) 52.48 4,84,063 1.04
ICICI Pru P.H.D Fund - Direct (IDCW) 52.48 4,84,063 1.04

Load more

Research Reports

DateBrokerActionPrices(₹) Report
17-Apr-2023Kotak Securities Buy 500

Stock Strength

Today's Low/High (₹)

1,025.00

1,039.45

Week Low/High (₹)

1,012.00

1,085.00

Month Low/High (₹)

1,012.00

1,130.00

Year Low/High (₹)

627.15

1,335.00

All time Low/High (₹)

369.00

1,335.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-2.55%-2.71%-1.14-1.05%
1 Month-3.09%-3.01%3.973.65%
3 Month-20.43%-20.49%-2.55-3.70%
6 Month19.48%19.79%5.164.36%
1 Year61.32%61.34%16.0816.69%
3 Year66.49%66.62%38.5940.60%

Company Info

Company Information

Managing Director & CEO : Yasir Yusufali Rawjee

Executive Director : Vinod Naik

Independent Non Exe. Director : Manju Agarwal

Independent Non Exe. Director : Taruvai Laxminarayanan Easwar

Chairman (Non-Executive) : HIREN KARSANBHAI PATEL

Independent Director : KAUSHIKBHAI NANDUBHAI PATEL

Independent Director : VIJAYKUMAR RATILAL SHAH

Independent Director : Savan Godialwala

Company Sec. & Compli. Officer : Rudalf Corriea

Registered Office: Plot No. 170-172 Chandramouli, Industrial Est.Mohol Bazarpeth,Solapur,Maharashtra-413213 Ph: 91-2189-234456/234246

Email:complianceofficer@glenmarklifesciences.com

URL:http://www.glenmarklifesciences.com

FAQs about Glenmark Life Sciences Ltd

1. What's the Glenmark Life Sciences Ltd share price today?
Glenmark Life Sciences Ltd share price was Rs 1,027.15 at 09:43 AM IST on 13th Dec 2024. Glenmark Life Sciences Ltd share price was down by 1.12% from the previous closing price of Rs 1,038.75. Glenmark Life Sciences Ltd share price trend:

  • Last 1 Month: Glenmark Life Sciences Ltd share price moved down by 3.09% on BSE
  • Last 3 Months: Glenmark Life Sciences Ltd share price moved down by 20.43% on BSE
  • Last 12 Months: Glenmark Life Sciences Ltd share price moved up by 61.32% on BSE
  • Last 3 Years: Glenmark Life Sciences Ltd price moved up by 66.49% on BSE


2. How can I quickly analyse the performance of the Glenmark Life Sciences Ltd stock?
The performance of the Glenmark Life Sciences Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 35.83
  • Price to book value ratio is 6.95
  • Dividend yield of 4.82
  • The EPS (trailing 12 months) of the Glenmark Life Sciences Ltd stock is Rs 28.69


3. What is the market cap of Glenmark Life Sciences Ltd?
Glenmark Life Sciences Ltd has a market capitalisation of Rs 12,588 crore.


4. What is Glenmark Life Sciences Ltd's 52-week high/low share price?
The Glenmark Life Sciences Ltd’s 52-week high share price is Rs 1,335.00 and 52-week low share price is Rs 627.25.


5. Is the Glenmark Life Sciences Ltd profitable?
On a consolidated basis, Glenmark Life Sciences Ltd reported a profit of Rs 95.32 crore on a total income of Rs 515.41 crore for the quarter ended 2024. For the year ended Sep 2024, Glenmark Life Sciences Ltd had posted a profit of Rs 95.32 crore on a total income of Rs 515.41 crore.


6. Which are Glenmark Life Sciences Ltd’s peers in the Health care sector?
Glenmark Life Sciences Ltd’s top 5 peers in the Health care sector are Granules India, Sanofi India, Marksans Pharma, Glenmark Life, Sanofi Consumer, P & G Health Ltd, Akums Drugs.


7. Who owns how much in Glenmark Life Sciences Ltd?
Key changes to the Glenmark Life Sciences Ltd shareholding are as follows:

  • Promoter holding in Glenmark Life Sciences Ltd has gone down to 75.00 per cent as of Sep 2024 from 82.85 per cent as of Dec 2023.